Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

Clinical trial NCT00005081 · COMPLETED

Trial details

NCT number: NCT00005081
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 2000-08-01
Primary completion: 2001-04-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.